Stimcell Energetics (STME) Change in Accured Expenses (2011 - 2026)
Stimcell Energetics' (STME) quarterly Change in Accured Expenses came in at -$7646.0 in Q1 2026, down 117.46% year-on-year from $43783.9 in Q1 2025, and up 67.14% quarter-over-quarter from -$23268.0 in Q4 2025.
Stimcell Energetics (STME) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Stimcell Energetics' Change in Accured Expenses history runs 14 years deep, the most recent figure standing at -$7646.0 for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 117.46% year-over-year to -$7646.0 in Q1 2026; TTM through Feb 2026 was -$1068.0, a 74.87% increase from a year earlier, with the FY2025 full-year figure at -$1108.0, up 86.96% from the prior year.
- Change in Accured Expenses improved to -$7646.0 in Q1 2026 per STME's latest filing, from -$23268.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $24531.0 in Q2 2022 and bottomed at -$34146.0 in Q4 2023.
- The 5-year median for Change in Accured Expenses is $3857.0 (2022), against an average of $219.88.
- Across the five-year window, Change in Accured Expenses soared 163.8% in 2022 and plunged 7454.42% in 2023, its largest moves.
- Year by year, Change in Accured Expenses stood at -$452.0 in 2022, then plunged by 7454.42% to -$34146.0 in 2023, then soared by 116.58% to $5662.0 in 2024, then plunged by 510.95% to -$23268.0 in 2025, then soared by 67.14% to -$7646.0 in 2026.
- Per Business Quant, the three latest STME Change in Accured Expenses figures stand at -$7646.0 (Q1 2026), -$23268.0 (Q4 2025), and $11739.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -7,646.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7,646.00 |
| Feb 28, 2026 | -7,646.00 |
| Nov 30, 2025 | -23,268.00 |
| Nov 30, 2025 | -23,268.00 |
| Aug 31, 2025 | 11,739.00 |
| Aug 31, 2025 | 11,739.00 |
| May 31, 2025 | 18,107.00 |
| May 31, 2025 | 18,107.00 |
| Feb 28, 2025 | -3,516.00 |
| Feb 28, 2025 | -3,516.00 |
| Nov 30, 2024 | 5,662.00 |
| Nov 30, 2024 | 5,662.00 |
| Aug 31, 2024 | -21,361.00 |
| Aug 31, 2024 | -21,361.00 |
| May 31, 2024 | 14,965.00 |
| May 31, 2024 | 14,965.00 |
| Feb 29, 2024 | 4,765.00 |
| Feb 29, 2024 | 4,765.00 |
| Nov 30, 2023 | -34,146.00 |
| Nov 30, 2023 | -34,146.00 |